You are here

Article info

Article menu
Oncolytic and local immunotherapy
Original research
Adenovirus vaccine targeting kinases induces potent antitumor immunity in solid tumors

Authors

  • Fei Zhu Cancer Institute, Xuzhou Medical University, Xuzhou, Jiangsu, ChinaCenter of Clinical Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, ChinaJiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Xuzhou Medical University, Xuzhou, Jiangsu, China PubMed articlesGoogle scholar articles
  • Zheng Lu Cancer Institute, Xuzhou Medical University, Xuzhou, Jiangsu, ChinaCenter of Clinical Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, ChinaJiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Xuzhou Medical University, Xuzhou, Jiangsu, China PubMed articlesGoogle scholar articles
  • Wenjing Tang Clinical Laboratory, The Affiliated Huai'an Hospital of Xuzhou Medical University and Huai'an Second Hospital, Huai'an, Jiangsu, China PubMed articlesGoogle scholar articles
  • Guangya Zhao Cancer Institute, Xuzhou Medical University, Xuzhou, Jiangsu, ChinaCenter of Clinical Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, ChinaJiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Xuzhou Medical University, Xuzhou, Jiangsu, China PubMed articlesGoogle scholar articles
  • Yingxiang Shao Cancer Institute, Xuzhou Medical University, Xuzhou, Jiangsu, ChinaCenter of Clinical Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, ChinaJiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Xuzhou Medical University, Xuzhou, Jiangsu, China PubMed articlesGoogle scholar articles
  • Bowen Lu Cancer Institute, Xuzhou Medical University, Xuzhou, Jiangsu, ChinaCenter of Clinical Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, ChinaJiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Xuzhou Medical University, Xuzhou, Jiangsu, China PubMed articlesGoogle scholar articles
  • Jiage Ding Department of Oncology, Xuzhou Central Hospital, Xuzhou Clinical School of Xuzhou Medical University, Xuzhou, Jiangsu, China PubMed articlesGoogle scholar articles
  • Yanyan Zheng Cancer Institute, Xuzhou Medical University, Xuzhou, Jiangsu, ChinaCenter of Clinical Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, ChinaJiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Xuzhou Medical University, Xuzhou, Jiangsu, China PubMed articlesGoogle scholar articles
  • Lin Fang Cancer Institute, Xuzhou Medical University, Xuzhou, Jiangsu, ChinaCenter of Clinical Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, ChinaJiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Xuzhou Medical University, Xuzhou, Jiangsu, China PubMed articlesGoogle scholar articles
  • Huizhong Li Cancer Institute, Xuzhou Medical University, Xuzhou, Jiangsu, ChinaCenter of Clinical Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, ChinaJiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Xuzhou Medical University, Xuzhou, Jiangsu, China PubMed articlesGoogle scholar articles
  • Gang Wang Cancer Institute, Xuzhou Medical University, Xuzhou, Jiangsu, ChinaCenter of Clinical Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, ChinaJiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Xuzhou Medical University, Xuzhou, Jiangsu, China PubMed articlesGoogle scholar articles
  • Renjin Chen College of Life Sciences, Xuzhou Medical University, Xuzhou, Jiangsu, China PubMed articlesGoogle scholar articles
  • Junnian Zheng Center of Clinical Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, ChinaJiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Xuzhou Medical University, Xuzhou, Jiangsu, China PubMed articlesGoogle scholar articles
  • Dafei Chai Cancer Institute, Xuzhou Medical University, Xuzhou, Jiangsu, ChinaJiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Xuzhou Medical University, Xuzhou, Jiangsu, ChinaDepartment of Medicine, Baylor College of Medicine, Houston, Texas, USA PubMed articlesGoogle scholar articles

Citation

Zhu F, Lu Z, Tang W, et al
Adenovirus vaccine targeting kinases induces potent antitumor immunity in solid tumors
Journal for ImmunoTherapy of Cancer 2024;12:e009869. doi: 10.1136/jitc-2024-009869
Online issue publication 
August 28, 2024

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.